Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke "FAMTAIS"

Not yet recruiting

Phase 2 Results N/A

Summary of Purpose

Proof-of concept clinical trials have indicated that the sphingosine-1-phosphate receptor modulator fingolimod may be efficacious in attenuating brain inflammation and improving clinical outcomes in patients with AIS as a single therapy beyond 4.5 hours of disease onset, or in combination with alteplase within 4.5 hours of disease onset. So in this study the investigators try to determine whether the addition of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 November 2016.

1 Nov 2016 11 Oct 2016 1 Oct 2018 1 Dec 2018 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts

  • Min Lou, MD,PhD